• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Osseon Therapeutics

edit

Osseon Therapeutics, Inc., headquartered in Santa Rosa, CA, is dedicated to developing and commercializing state of the art medical devices for minimally invasive treatments for degenerative bone and joint disease, including the treatment of vertebral compression fractures. The company’s patented, steerable delivery system offers more treatment options than other commercial solutions as well as offering significant advantages in procedural efficiency and cost. By improving the treatment of compression fractures within the thoracic and lumbar vertebral spine, Osseon offers new, forward thinking solutions to patients suffering from these maladies, as well as to the physicians and medical facilities that treat them. Osseon’s products are distributed globally.

Recent Milestones

edit

• 
  Osseon Therapeutics received $14M in Private Equity funding. (1/31/13)
  Posted 1/31/13 at 10:00pm via osseon.com
• 
  Osseon Therapeutics added Chad White as Vice President of Sales. (1/1/09)
  Posted 1/31/13 at 10:00pm
• 
  Osseon Therapeutics added Connie Esch as Area Director of Sales.
  Posted 2/7/13 at 3:48am
• 
  Osseon Therapeutics added Keith Burger as Director of Research & Development.
  Posted 4/19/13 at 2:42am
• 
  Osseon Therapeutics added Rob Weathers as Director of Quality.
  Posted 4/19/13 at 2:42am
• 
  Osseon Therapeutics added Ron Clough as CEO.
  Posted 1/31/13 at 10:00pm
• 
  Osseon Therapeutics added Spencer Hill as Controller/Director of Finance.
  Posted 4/19/13 at 2:42am

Videos

Screenshots

edit

Sources

1. Osseon® Closes $14 Million Equity Financing (osseon.com) [edit]